共 50 条
- [43] Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States Drugs & Therapy Perspectives, 2022, 38 : 490 - 498
- [50] Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020 ANNALS OF GASTROENTEROLOGY, 2023, 36 (06): : 670 - +